title: Pharmacoeconomic guidelines should prescribe inclusion of indirect medical costs! A response to Grima et Al.
authors.affiliation: Institute of Health Policy & Management/institute for Medical Technology Assessment, Erasmus University Rotterdam, PO Box 1738, 3000 DR, Rotterdam, The Netherlands. vanbaal@bmg.eur.nl
authors.forename: Pieter
authors.initials: P
authors.lastname: van Baal
authors.forename: David
authors.initials: D
authors.lastname: Meltzer
authors.forename: Werner
authors.initials: W
authors.lastname: Brouwer
mesh_terms: D006801:Humans; D012051:Reimbursement Mechanisms / Q000191:economics*; D006435:Renal Dialysis / Q000191:economics*; D051436:Renal Insufficiency, Chronic / Q000628:therapy*